4-(Trifluoromethylthio)benzylamine → 2-(5-isoquinolinyl)-N-{4-[(trifluoromethyl)thio]benzyl}butanamide

HRID 586044

Reaktionsgleichung

Reaktionsgleichung von HRID 586044
[F:1][C:2]([F:13])([F:12])[S:3][C:4]1[CH:11]=[CH:10][C:7]([CH2:8][NH2:9])=[CH:6][CH:5]=1.[CH:14]1[C:23]2[C:18](=[C:19]([CH:24]([CH2:28][CH3:29])[C:25](O)=[O:26])[CH:20]=[CH:21][CH:22]=2)[CH:17]=[CH:16][N:15]=1.C1C2C(=C(CC(O)=O)C=CC=2)C=CN=1>>[CH:14]1[C:23]2[C:18](=[C:19]([CH:24]([CH2:28][CH3:29])[C:25]([NH:9][CH2:8][C:7]3[CH:10]=[CH:11][C:4]([S:3][C:2]([F:12])([F:1])[F:13])=[CH:5][CH:6]=3)=[O:26])[CH:20]=[CH:21][CH:22]=2)[CH:17]=[CH:16][N:15]=1

Komponenten

4

Edukt 3

HCID 27778754-(Trifluoromethylthio)benzylamineHCID 120187082-(Isoquinolin-5-YL)acetic acidHCID 223376822-(Isoquinolin-5-yl)butanoic acid

Produkt 1

HCID 111656042-(5-isoquinolinyl)-N-{4-[(trifluoromethyl)thio]benzyl}butanamide

Versuchsvorschrift

The title compound was prepared using the procedure described in Example 222B using 4-[(trifluoromethyl)thio]benzylamine and 2-(5-isoquinolinyl)butanoic acid instead of 4-(trifluoromethoxy)benzylamine and 5-isoquinolinylacetic acid. MS (ESI+) m/z 405 (M+H)+; MS (ESI−) m/z 403 (M−H)−; 1H NMR (DMSO, 300 MHz) δ 0.91 (t, J 7.5, 3H), 1.81 (m, 1H), 2.21 (m, 1H), 3.39 (m, 1H), 4.34 (m, 2H), 7.31 (m, 2H), 7.58 (m, 2H), 7.62 (d, J 7.8, 1H), 8.00 (m, 2H), 8.22 (d, J 7.1, 1H), 8.45 (m, 1H), 8.77 (m, 1H), 8.82 (m, 1H), 9.06 (t, J 6.8, 1H), 9.87 (s, 1H), 10.30 (br s, 1H); Anal. Calcd for C21H19F3N2OS+0.65 HCl: C, 58.91; H, 4.63; N, 6.54. Found: C, 59.24; H, 4.30; N, 6.60.

Quellen und Nachweise

ORD-Eintrag
ord-7e4d5f57b7b8495caf19a327570710dc
Quelldatensatz
uspto-grants-2005_08
Patentnummer
US06933311B2

Verknüpfte Notizen

Wird geladen…